A detailed history of Gemmer Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gemmer Asset Management LLC holds 3,750 shares of GILD stock, worth $331,087. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,750
Previous 3,938 4.77%
Holding current value
$331,087
Previous $270,000 16.3%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$66.59 - $83.99 $12,518 - $15,790
-188 Reduced 4.77%
3,750 $314,000
Q2 2024

Jul 15, 2024

BUY
$63.15 - $72.88 $248,684 - $287,001
3,938 New
3,938 $270,000
Q2 2022

Jul 22, 2022

SELL
$57.72 - $65.01 $59,278 - $66,765
-1,027 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$57.92 - $72.58 $1,448 - $1,814
-25 Reduced 2.38%
1,027 $61,000
Q4 2021

Jan 21, 2022

BUY
$64.88 - $73.64 $194 - $220
3 Added 0.29%
1,052 $76,000
Q3 2021

Oct 19, 2021

BUY
$67.69 - $73.03 $203 - $219
3 Added 0.29%
1,049 $73,000
Q2 2021

Jul 23, 2021

BUY
$63.47 - $69.35 $1,459 - $1,595
23 Added 2.25%
1,046 $72,000
Q1 2021

Apr 20, 2021

BUY
$60.0 - $68.46 $60 - $68
1 Added 0.1%
1,023 $66,000
Q4 2020

Jan 28, 2021

SELL
$56.65 - $64.55 $4,701 - $5,357
-83 Reduced 7.51%
1,022 $60,000
Q3 2020

Oct 21, 2020

BUY
$62.1 - $78.08 $62 - $78
1 Added 0.09%
1,105 $70,000
Q2 2020

Jul 31, 2020

BUY
$72.34 - $84.0 $8,102 - $9,408
112 Added 11.29%
1,104 $85,000
Q1 2020

May 01, 2020

BUY
$62.63 - $80.22 $9,206 - $11,792
147 Added 17.4%
992 $74,000
Q4 2019

Jan 17, 2020

SELL
$61.62 - $67.78 $739 - $813
-12 Reduced 1.4%
845 $55,000
Q3 2019

Oct 11, 2019

BUY
$62.51 - $69.0 $875 - $966
14 Added 1.66%
857 $54,000
Q2 2019

Jul 18, 2019

BUY
$61.87 - $69.38 $61 - $69
1 Added 0.12%
843 $57,000
Q1 2019

Apr 17, 2019

SELL
$62.53 - $70.05 $5,315 - $5,954
-85 Reduced 9.17%
842 $55,000
Q4 2018

Jan 18, 2019

SELL
$60.54 - $79.0 $544 - $711
-9 Reduced 0.96%
927 $58,000
Q3 2018

Oct 12, 2018

SELL
$71.28 - $78.92 $6,985 - $7,734
-98 Reduced 9.48%
936 $72,000
Q2 2018

Jul 18, 2018

SELL
$64.88 - $75.68 $389 - $454
-6 Reduced 0.58%
1,034 $73,000
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $13,256 - $16,161
-182 Reduced 14.89%
1,040 $78,000
Q4 2017

Jan 16, 2018

BUY
$71.15 - $83.52 $10,885 - $12,778
153 Added 14.31%
1,222 $88,000
Q3 2017

Oct 12, 2017

BUY
$72.11 - $85.47 $77,085 - $91,367
1,069
1,069 $87,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.